Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
The coronavirus disease 2019 (COVID-19) pandemic has dramatically changed because of virus mutations, vaccine dissemination, treatment development and policies, among other factors. These factors have a dynamic and complex effect on the characteristics and outcomes of patients. Therefore, there is a...
Main Authors: | Koichi Miyashita, Hironao Hozumi, Kazuki Furuhashi, Eiji Nakatani, Yusuke Inoue, Hideki Yasui, Masato Karayama, Yuzo Suzuki, Tomoyuki Fujisawa, Noriyuki Enomoto, Naoki Inui, Toshiyuki Ojima, Takafumi Suda |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2022.2155250 |
Similar Items
-
Outcomes of COVID-19 in the Omicron-predominant wave: large-scale real-world data analysis with a comparison to influenza
by: Koichi Miyashita, et al.
Published: (2025-02-01) -
Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
by: Koichi Miyashita, et al.
Published: (2024-02-01) -
Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias
by: Hironao Hozumi, et al.
Published: (2024-07-01) -
Evaluation of the Correspondence between the Concentration of Antimicrobials Entering Sewage Treatment Plant Influent and the Predicted Concentration of Antimicrobials Using Annual Sales, Shipping, and Prescriptions Data
by: Takashi Azuma, et al.
Published: (2022-04-01) -
Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy
by: Masato Karayama, et al.
Published: (2021-12-01)